source
- Moderna reports 29% revenue rise as COVID vaccine sales stay steady amid global uptakeModerna said its quarterly revenue jumped 29% to $1.3 billion, driven by continued demand for its COVID-19 shots. The company has generated $1.8 billion in revenue so far this year, according to CF…
- New evidence links AAV gene therapies to tumor risk, raising safety concernsRecent cases reported this year provide strong evidence that adeno-associated viruses (AAVs), the vectors used to deliver therapeutic genes, can trigger tumor formation. The findings settle a two‑d…